Article Details
Retrieved on: 2020-12-08 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Additionally, 4D is advancing 4D-110 (licensed from <b>Roche</b>) for the treatment of choroideremia in Phase 1 trials, for which it expects initial clinical data ...
Article found on: www.thestreet.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here